Sichuan Dowell Science and Technology Inc. (SHE:300535)
China · Delayed Price · Currency is CNY 14.55
-0.09 (-0.61%)
Jun 18, 2026, 3:04 PM CST
SHE:300535 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 696.66 | 696.8 | 733.65 | 702.21 | 508.1 | 627.12 |
Other Revenue | 16.02 | 16.02 | 19.49 | 22.39 | 2.28 | 2.7 |
| 712.68 | 712.82 | 753.14 | 724.6 | 510.39 | 629.82 | |
Revenue Growth (YoY) | -4.73% | -5.35% | 3.94% | 41.97% | -18.96% | 34.11% |
Cost of Revenue | 429.76 | 430.36 | 488.52 | 508.64 | 377.05 | 397.56 |
Gross Profit | 282.93 | 282.46 | 264.62 | 215.96 | 133.34 | 232.25 |
Selling, General & Admin | 174.19 | 159.62 | 133.68 | 119.96 | 102.15 | 108.88 |
Research & Development | 55.37 | 56.43 | 49.8 | 42.36 | 29.8 | 42.24 |
Other Operating Expenses | 6.54 | 5.53 | 1.14 | 2.05 | 5.64 | 4.97 |
Operating Expenses | 241.42 | 224.47 | 184.05 | 168.95 | 138.18 | 159.75 |
Operating Income | 41.5 | 57.99 | 80.58 | 47.01 | -4.84 | 72.5 |
Interest Expense | -8.45 | -8.71 | -10.97 | -8.43 | -6.54 | -4.33 |
Interest & Investment Income | 0.22 | 0.25 | 0.44 | 0.19 | 0.1 | 0.13 |
Earnings From Equity Investments | 1.2 | - | - | -6.36 | -1.53 | 0.7 |
Currency Exchange Gain (Loss) | 1.95 | 1.95 | -0.04 | -0.25 | -5.8 | -0.22 |
Other Non Operating Income (Expenses) | -3.23 | -3.69 | -6.01 | -1.39 | -1.38 | -1.04 |
EBT Excluding Unusual Items | 33.2 | 47.79 | 64 | 30.77 | -20.01 | 67.74 |
Impairment of Goodwill | - | - | -2.17 | - | - | - |
Gain (Loss) on Sale of Investments | -11.21 | -11.21 | -68.37 | - | - | - |
Gain (Loss) on Sale of Assets | -0.3 | -0.24 | -2.46 | 0.05 | 0.01 | 0.02 |
Asset Writedown | -0.09 | -0.1 | -27.03 | -23.03 | -0.08 | -0.04 |
Other Unusual Items | 6.61 | 6.28 | 4.61 | 3.09 | 7.09 | 3.94 |
Pretax Income | 28.21 | 42.53 | -31.41 | 10.87 | -12.99 | 71.67 |
Income Tax Expense | 6.04 | 6.38 | 3.44 | 7.32 | 4.21 | 5.98 |
Earnings From Continuing Operations | 22.18 | 36.15 | -34.84 | 3.55 | -17.2 | 65.69 |
Minority Interest in Earnings | -0.02 | -0.34 | 23.39 | 24.88 | 15.37 | 0.15 |
Net Income | 22.15 | 35.81 | -11.45 | 28.43 | -1.83 | 65.84 |
Net Income to Common | 22.15 | 35.81 | -11.45 | 28.43 | -1.83 | 65.84 |
Net Income Growth | - | - | - | - | - | 15.44% |
Shares Outstanding (Basic) | 106 | 105 | 105 | 105 | 104 | 102 |
Shares Outstanding (Diluted) | 106 | 105 | 105 | 105 | 104 | 103 |
Shares Change (YoY) | 0.88% | 0.32% | 0.27% | 0.67% | 1.21% | 1.25% |
EPS (Basic) | 0.21 | 0.34 | -0.11 | 0.27 | -0.02 | 0.64 |
EPS (Diluted) | 0.21 | 0.34 | -0.11 | 0.27 | -0.02 | 0.64 |
EPS Growth | - | - | - | - | - | 14.02% |
Free Cash Flow | -34.27 | -18.73 | -55.21 | -38.48 | -13.94 | -53.73 |
Free Cash Flow Per Share | -0.32 | -0.18 | -0.53 | -0.37 | -0.13 | -0.52 |
Dividend Per Share | 0.105 | 0.105 | - | 0.070 | - | 0.100 |
Dividend Growth | - | - | - | - | - | 11.11% |
Gross Margin | 39.70% | 39.63% | 35.14% | 29.80% | 26.13% | 36.88% |
Operating Margin | 5.82% | 8.13% | 10.70% | 6.49% | -0.95% | 11.51% |
Profit Margin | 3.11% | 5.02% | -1.52% | 3.92% | -0.36% | 10.45% |
Free Cash Flow Margin | -4.81% | -2.63% | -7.33% | -5.31% | -2.73% | -8.53% |
EBITDA | 84.16 | 102.07 | 130.33 | 87.34 | 30.52 | 107.18 |
EBITDA Margin | 11.81% | 14.32% | 17.30% | 12.05% | 5.98% | 17.02% |
D&A For EBITDA | 42.66 | 44.08 | 49.76 | 40.33 | 35.36 | 34.68 |
EBIT | 41.5 | 57.99 | 80.58 | 47.01 | -4.84 | 72.5 |
EBIT Margin | 5.82% | 8.13% | 10.70% | 6.49% | -0.95% | 11.51% |
Effective Tax Rate | 21.39% | 15.01% | - | 67.33% | - | 8.34% |
Revenue as Reported | 712.68 | 712.82 | 753.14 | 724.6 | 510.39 | 629.82 |
Advertising Expenses | - | 1.31 | 1.97 | 1.31 | 2.65 | 0.65 |